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104 M. Costa et al.facilitate the study of human EC physiology, using a defined serum-free protocol. Human embryonic stem cells
(hESC-ECs) differentiated under serum-free conditions generated CD34+KDR+ endothelial progenitor cells after 6 days
that could be further expanded in the presence of vascular endothelial growth factor (VEGF). The resultant EC
population expressed CD31 and TIE2/TEK, took up acetylated low-density lipoprotein (LDL) and up-regulated
expression of ICAM-1, PAI-1 and ET-1 following treatment with TNFα. Immunofluorescence studies indicated that a key
mediator of vascular tone, endothelial nitric oxide synthase (eNOS), was localised to a perinuclear compartment of
hESC-ECs, in contrast with the pan-cellular distribution of this enzyme within human umbilical vein ECs (HUVECs).
Further investigation revealed that that the serum-associated lipids, lysophosphatidic acid (LPA) and platelet
activating factor (PAF), were the key molecules that affected eNOS localisation in hESC-ECs cultures. These studies
illustrate the feasibility of EC generation from hESCs and the utility of these cells for investigating environmental cues
that impact on EC phenotype. We have demonstrated a hitherto unrecognized role for LPA and PAF in the regulation of
eNOS subcellular localization.
© 2012 Elsevier B.V. All rights reserved.Introduction
Endothelial cells play a pivotal role in the homeostasis of the
cardiovascular system and endothelial dysfunction is a prom-
inent feature in conditions such as diabetes, hypertension and
obesity, leading causes of morbidity and mortality in the
Western world. In vitro, ECs are generally cultured in
serum-containing media, which confounds attempts to appor-
tion the contributions of individual components within the
medium to growth and differentiation. In this context, a
protocol that enabled the production and maturation of ECs in
a completely defined environment would facilitate the
assessment of the effects of serum-associated factors on EC
development, growth and function.
PluripotenthESCs (Thomsonet al., 1998), derived fromthe inner
cell mass of the blastocyst stage embryo, have the potential to
differentiate into all cell types found in the human body. ECs
differentiated from hESCs (hESC-ECs) are phenotypically similar to
primary ECs and are capable of contributing to neo-vascularisation
(Levenberg et al., 2002; Lu et al., 2007; Chen et al., 2007; Lesman
et al., 2010; Kane et al., 2010, 2012; Cho et al., 2007; Kaupisch et
al., 2012; Kraehenbuehl et al., 2011; Lee et al., 2011; Li et al.,
2011;Moonet al., 2011;Nourse et al., 2010; Tianet al., 2009; Xiong
et al., 2011). Although methods for the generation of ECs from
hESCs are well established, without exception, these methods
include either serum or serum derivatives that are likely to
adversely affect the reproducibility of differentiation and the
ability to transfer protocols between laboratories. We have
developed a strategy to produce ECs from hESCs using a
defined medium (AEL) that is free from serum and/or
serum-derived constituents (Ng et al., 2008). During
studies exploring the function of hESC-ECs generated with
this platform, we observed that the subcellular localization
of the key EC enzyme, eNOS, differed between ECs gen-
erated in vitro from hESCs and those cultured from human
umbilical cord veins (HUVECs). Subsequent experiments in
which AEL medium was supplemented with candidate
molecules present in serum identified the serum-associated
lipids, lysophosphatidic acid (LPA) and platelet activating
factor (PAF), as regulators of eNOS subcellular localization
in hESC-ECs. These experiments demonstrate the utility of a
defined differentiation system for identifying novel factors
that influence the phenotype of ECs and as a platform for
investigating modulators of EC function.Methods
hESC culture and differentiation
The hESC lines HES3 (Richards et al., 2002), H9 (WiCell
Research Institute (Madison, WI, USA), MEL1 (Millipore) and
the induced pluripotent stem cell (iPSC) line Df 19-9-7T
(WiCell Research Institute (Madison, WI, USA) were
maintained as previously described (Costa et al., 2008). For
differentiation, cells were harvested using TrypLE Select™
(Invitrogen Corporation) and passed through a 35 μm cell
strainer cap to obtain a uniform single cell suspension.
Following centrifugation, cells were resuspended at a density
of 4×105 cells/ml in APEL medium (Ng et al., 2008) in which
the concentration of polyvinylalcohol (PVA) was increased
from 0.5 mg/ml to 1 mg/ml and the Protein Free Hybridoma
Medium II component was omitted. During the first 2 days of
differentiation, medium was supplemented with 40 ng/ml
human bone morphogenetic protein 4 (BMP4), 25 ng/ml
human stem cell factor (SCF), 50 ng/ml human vascular
endothelial growth factor (VEGF), 25 ng/ml fibroblast
growth factor 2 (FGF2), 5 ng/ml fibroblast growth factor
8 (FGF8) and 20 μmol/L lithium chloride. To prevent
adhesion of embryoid bodies (EBs), tissue culture dishes
were coated with poly(2-hydroxyethyl methacrylate) (10%
stock solution, plated at 1 ml/10 cm2) (Folkman and
Moscona, 1978), prior to seeding 0.2 ml of cell suspension/
cm2. From differentiation day (d) 2 to d6, cells were
cultured in fresh AEL medium (same formulation of APEL
but lacking PVA) containing the same factors as above. On
day 6 (d6), cells were disaggregated and CD34+KDR+
progenitors isolated by flow cytometry. These were then
cultured in AEL media containing 50 ng/ml VEGF (AEL/
VEGF medium) on fibronectin-coated tissue culture dishes
(1 μg/cm2).Flow cytometric analysis of cells
Cells or EBs were harvested as previously described (Ng
et al., 2005) and incubated with primary and secondary
antibodies as indicated (Supplementary Table 1) prior to
flow cytometric analysis or isolation using FACSAria or a BD
Influx cell sorter (Becton Dickinson).
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progenitor frequency
To determine endothelial progenitor cell (EPC frequency),
single CD34+KDR+ cells viably sorted from d6 EBs were
deposited into individual wells of a 96-well tray using theCD133-
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107Derivation of endothelial cells from human embryonic stem cells in fully defined medium100 ng/ml SCF, 30 ng/ml of each of interleukin (IL)3, IL6,
granulocyte-macrophage colony stimulating factor (GMCSF)
and thrombopoietin (TPO) and 3 U/ml erythropoietin (EPO).
Hematopoietic colonies were scored 7–10 days later.In vitro endothelial tube formation
Growth factor reduced BD Matrigel™ (Becton Dickinson) was
thawed at 4 °C and 200 μl was dispensed into wells of a
48-well tray and polymerized at 37 °C for 30 min. Fifty
thousand d12 differentiated hESCs (CD34− or CD34+) or
HUVECs in 200 μl of AEL/VEGF or EGM-2™ (Lonza) media,
respectively, were seeded onto the polymerized Matrigel,
and incubated overnight in a humidified atmosphere of 5%
CO2 at 37 °C (Kubota et al., 1988). Images of Matrigel
cultures were captured using a stereomicroscope (Leica).SDS-PAGE, zymography and ELISA studies
Day 12 hESC-ECs or HUVECs were grown in AEL/VEGF or EGM-2
media, respectively, and treatedwith 10 ng/ml TNFα for 16 h.
Conditioned medium was collected, centrifuged at 10,000
revolutions per min (r.p.m.) (9,000 g) for 1 min and the
supernatant was transferred into an eppendorf tube. MMP2
and MMP9 activity was determined by zymography as previ-
ously described (Fridman et al., 1995; Granelli-Piperno and
Reich, 1978; Vinh et al., 2008). The PAI-1 protein concentra-
tion in the CM was assayed using ELISA kits for PAI-1 (Trinity
Biotech, Ireland), ICAM-1, VCAM-1 and E-selectin proteins (all
from R&D Systems, MN) (Liu et al., 2009).Reverse transcriptase PCR and gene
expression profiling
For reverse transcriptase PCR analysis, total RNA was
purified using a High Pure RNA Isolation Kit (Roche Applied
Science) according to the manufacturer's instructions, cDNA
generated using reverse transcriptase, and PCR performed,
as previously described (Liu et al., 2009). The primers used
in this study for VACM-1, ICAM-1, PAI-1, E-selectin and ET-1
(Liu et al., 2009) are given in Supplementary Table 2. For
microarray analyses, RNA preparation and gene expression
profiling were performed essentially as described previous-
ly (Kim et al., 2012). Data are available at ArrayExpress
(http://www.ebi.ac.uk/microarray_as/ae/) via accession
number E-MEXP-3709. In Fig. 5, comparison of our data with
transcriptional profiles derived by Medina and colleagues
(Medina et al., 2010) utilised data deposited in the NCBIFigure 2 Endothelial and hematopoietic colony forming capacity
merged images of a representative EC colony derived from single CD3
of wells containing viable cells after 9 days (mean±s.e.m. of n=6).
that contained viable cells at 9 days (mean±s.e.m. of n=6). D–F. Day
fractions, cultured in conditions favouring the expansion of hESC-E
inducing cytokines. Images (E) show the adherent cell layer genera
colonies forming in methylcellulose cultures. G. The histograms show
from each sorted fraction after the indicated period of culture. E
pb0.05. susp, cells in suspension; adh, adherent cells.gene expression omnibus (GEO) available at http://www.
ncbi.nlm.nih.gov/geo with accession number GSE20283.
Acetylcholine induced cytoplasmic calcium
response, Immunofluorescence analysis,
and LDL uptake
Confluent cultures of d12 hESC-ECs on 9 mm glass coverslips
were washed briefly in HBSS containing (mmol/L): 137 NaCl,
5.4 KCl, 0.44 KH2PO4, 0.5 MgCl2, 0.4 MgSO4, 4 NaHCO3, 0.3
Na2HPO4, 1.3 CaCl2, 10 HEPES, 5.6 glucose, pH 7.4. The cells
were then loaded with Fluo-4-AM (5 μmol/L) in the dark at
room temperature for 20 min. The coverslip was transferred
to a tissue bath (Warner Instruments, Hamden, CT) mounted
on an Olympus IX71 inverted microscope and continuously
superfused at 2 ml/min with HBSS at 33 °C for 15 min to
allow cleavage of the Fluo-4-AM by cytoplasmic esterases.
The cells were viewed under a confocal microscope
illuminated by a krypton/argon laser at 488 nm, and the
light passed through a Yokogawa CSU22 Nipkow spinning disc
(Yokogawa Australia Pty, Macquarie Park, NSW, Australia) to
a high-sensitivity electron-multiplying Andor iXon CCD
camera (Andor Technology PLC, Belfast, Ireland). Full
frames were collected at 1 s intervals.
For immunofluorescence labelling, d9 CD34+KDR+ cells
purified by flow cytometry were cultured for 3 days on
fibronectin-coated glass cover slips before being processed
for immunofluorescence analysis and confocal microscopy as
described previously (Kim et al., 2012). LDL uptake was
performed as described by Yu et al. (2012) and Kim et al.
(2012).
Data analysis
For flow cytometry and progenitor frequency analyses, data is
expressed as mean±standard error of the mean. For these
experiments pb0.05 was considered statistically significant.
For hematopoietic colony assay (Fig. 2G) and secreted protein
ELISA (Fig. 4B), data was compared using a paired t-test.
Results
Generation, expansion and characterisation of
hESC-ECs
In order to generate endothelial precursors, hESCs were
differentiated in APEL medium (Ng et al., 2008) supplemented
with BMP4, SCF, VEGF, FGF2 and LiCl in low attachment tissue
culture dishes. After 1 day, dissociated hESCs aggregated toof CD34+KDR+ cells. A. Brightfield (BF), fluorescence (GFP) and
4+KDR+ precursor cell. B. Histogram summarising the proportion
C. Histogram indicating the distribution of colony sizes in wells
6 CD34+KDR+ cells were sorted into CD34+KDRhi and CD34+KDRlo
Cs, harvested daily and cultured in methylcellulose with blood
ted from each fraction. F. Examples of erythroid and myeloid
the frequency of hematopoietic colony forming cells generated
rror bars display the s.e.m. of 3 independent experiments. *,
108 M. Costa et al.form heterogeneous EBs that increased in size over the
following 5 days (Fig. 1A). Undifferentiated hESCs expressed
CD133, CD9, low levels of KDR and CD105 (Endoglin), TIE2/TEK
and E- CADHERIN butwere negative for CD34 and VE- CADHERIN
(Fig. 1B). By day 6, up to 50% of the differentiating cells
expressed CD34, CD31, KDR, CD105, TIE2/TEK, VE-CADHERIN
AND E-CADHERIN (Fig. 1B, Supplementary Fig. 1, Supplemen-
tary Table 1), a phenotype suggestive of an EPC (Asahara et al.,
1997; Chen et al., 2007; Nourse et al., 2010; Peichev et al.,
2000; Sun et al., 2012; Tatsumi et al., 2011; Timmermans et
al., 2009; Wang et al., 2004, 2007). The immunophenotype of
d6 CD34+KDR+ cells was similar to that of human umbilical vein
endothelial cells (HUVECs), except that HUVECs expressed CD9
but had lost expression of the progenitor marker CD34
(Fig. 1B). Day 6 CD34+KDR+ cells isolated by flow cytometry
were grown as a monolayer in AEL medium supplemented with
50 ng/ml VEGF (AEL/VEGF). By d12 of differentiation, cultures
contained a uniform population of cells (denoted hESC-ECs)
that expressed high levels of CD34, CD31, KDR, CD105, TIE2/
TEK, VE- CADHERIN and E-CADHERIN. Interestingly, these d12
hESC-ECs had now up-regulated expression of CD9, similar to
HUVECs (Fig. 1B and C). Similar differentiation kinetics were
observed when this protocol was applied to other hESC lines
including H9, MEL1 and the induced pluripotent stem cell
(iPSC) line Df 19-9-7T (Fig. 1D).Endothelial and hematopoietic progenitor frequency
of d6 CD34+KDR+ cells
Previous studies have demonstrated that either CD34+ or
KDR+ cells derived from the in vitro differentiation of hESCs
(Chen et al., 2007; James et al., 2010; Kennedy et al., 2007;
Lu et al., 2007; Ma et al., 2007; Park et al., 2009;
Prado-Lopez et al., 2010; Sun et al., 2012; Tian et al.,
2009; Wang et al., 2004, 2012; Woll et al., 2008; Zambidis et
al., 2008) or present in the circulation (Timmermans et al.,
2009) include precursors for both blood and endothelium. To
quantify the fraction of CD34+KDR+ cells within day 6 EBs
with endothelial potential, single cells purified by flow
cytometry were deposited into individual wells of 96-well
trays containing AEL/VEGF medium. After 9 days, the
number of adherent cells in each well was counted
(Fig. 2A). Whilst 20.6±3.0% (Fig. 2B, Supplementary Table
3A) of wells contained viable ECs, the majority of these
(53.6±4.8%) contained between 1 and 4 cells (Fig. 2C). Small
clusters of 5–30 cells were present in 39.7±3.8% of wells
whilst 6.4±1.7% of wells contained colonies comprising
30–120 cells, potentially representing 6–8 doublings of the
initiating cell (Fig. 2C, Supplementary Table 3A). Large
colonies containing N120 cells were only observed infre-
quently (0.4±0.2% of wells).
CD34+KDR+ cells present in d6 EBs could be sub-
fractionated on the basis of KDR expression levels, enabling
isolation of CD34+KDRhi (55%±2.1 of the total CD34+KDR+
fraction, n=4) and CD34+KDRlo populations (Fig. 2D). When
these two fractions were cultured in AEL/VEGF, only the
CD34+KDRhi formed confluent EC monolayers (Fig. 2E),
demonstrating these conditions enrich for the CD34+KDRhi
fraction. Conversely, when d6 CD34+KDRhi and CD34+KDRlo
cells were seeded into methylcellulose cultures supple-
mented with hematopoietic growth factors, the highestfrequency of hematopoietic colonies (Fig. 2F) was observed
in the CD34+KDRlo fraction (135±47 colonies/104 cells
compared with 36±15 colonies/104 cells from CD34+KDRhi
fraction) (Fig. 2G, Supplementary Table 3B).
To assess the selectivity of our culture conditions for
maintaining ECs and eliminating hematopoietic precur-
sors, sorted d6 CD34+KDRhi and CD34+KDRlo cells were
cultured in AEL/VEGF for 1–3 days before seeding into
methylcellulose cultures. After the first day of culture in
AEL/VEGF, both adherent cells with an EC-like appearance
and suspension cells were observed. Methylcellulose
colony forming assays indicated that hematopoietic activ-
ity was predominantly associated with the adherent cells
originating from the CD34+KDRlo fraction (462±294 CFC/
104 cells), whilst the frequency of blood colony forming
cells in cultured CD34+KDRhi cells remained very low (38±
17 CFC/104 cells) (Fig. 2G, Supplementary Table 3B). The
frequency of colony forming cells in both fractions rapidly
declined to negligible levels over 5 days of culture in AEL/
VEGF (Fig. 2G, Supplementary Table 3B and data not
shown). Our findings suggest that hESC-EPCs are derived
from CD34+KDRhi cells whilst hematopoietic precursors are
enriched in the CD34+KDRlo fraction. Importantly, our
findings confirmed that d6 CD34+KDRhi cells expanded in
AEL/VEGF for more than 3 days gave rise to a highly
uniform and pure population of ECs.In vitro function of hESC-ECs
To further characterise the hESC-derived ECs, we performed
a number of in vitro assays comparing d12 hESC-ECs with
HUVECs. Monolayers of hESC-ECs derived from CD34+KDRhi
cells were morphologically indistinguishable from HUVECs,
whilst cultures of CD34−KDR− cells contained infrequent
colonies of flattened cells suggestive of smooth muscle
(Fig. 3A). Following overnight culture in matrigel, hESC-ECs
formed tube-like structures similar to those generated by
HUVECs. These structures were not observed in cultures of
CD34−KDR− cells (Fig. 3B). Cells were assessed for their
ability to take up acetylated low-density lipoprotein (LDL),
an attribute of ECs and macrophages. Similar to HUVECs,
hESC-ECs took up diI-labelled acetylated LDL, while the
CD34−KDR− cells did not (Fig. 3C). Also like HUVECs,
hESC-ECs expressed von Willebrand factor (vWF) (Fig. 3D).
The endothelium responds to inflammatory mediators,
such as TNFα by up-regulating adhesion molecules implicat-
ed in the capture and adhesion of circulating leukocytes,
including ICAM-1, VCAM-1, E-SELECTIN, as well as inducing
factors involved in fibrinolysis and vasoconstriction, such as
PAI-1 and ET-1 (Liu et al., 2009; Vinh et al., 2008). Whilst
unstimulated day 12 hESC-ECs expressed low levels of
transcripts encoding these markers, TNFα-treatment in-
duced transcripts for ICAM-1, PAI-1 and ENDOTHELIN-1
(Fig. 4A). However, TNFα-mediated induction of VCAM-1
and E-SELECTIN RNA was detected in only one of three
independent experiments, suggesting that hESC-ECs were
immature. Conversely, all of these markers were strongly
induced in HUVECs treated with TNFα (Fig. 4A).
This activating effect of TNFα treatment on HUVECs was
corroborated by the robust levels of ICAM-1, VCAM-1 and
E-SELECTIN protein measured by ELISA in HUVEC conditioned
HUVECCD34-KDR- CD34+KDR+
DiI-AcLDL
vWF
A
B
C
D
BF
Figure 3 hESC-ECs form tube-like structures in Matrigel and take up diI-Ac-LDL. Phenotypic characterisation of hESC-ECs A. Bright
field images of d6 CD34−KDR− cells and CD34+KDR+ cells following 6 days of further in vitro expansion and HUVECs. The CD34+KDR+
cells formed a monolayer comparable to HUVECs. B. Bright field images of d 12 CD34−KDR− cells, CD34+KDR+ cells and HUVECs
following overnight culture in matrigel. Only CD34+KDR+ cells and HUVECs formed tube-like structures C. When these cells were
assessed for their ability to take up diI-labelled acetylated LDL (DiI-Ac-LDL), CD34+KDR+ cells and the HUVECs were positive, whilst
the CD34−KDR− cells were negative. D. Immunohistochemistry demonstrating that the CD34+KDR+ cells expressed vWF. Panels A–C,
original magnification ×50; D, original magnification ×120.
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treated with TNFα released similar levels of ICAM-1,
although V-CAM1 was not detected and only low levels of
E- SELECTIN were measured in conditioned medium (Fig. 4B,
Supplementary Table 4A).
Flow cytometry analysis demonstrated that ICAM-1 was
up-regulated in hESC-ECs and HUVECs in response to TNFα
treatment (Fig. 4C, Supplementary Table 4B and C).
Consistent with the results of RNA and conditioned mediumanalyses, up-regulation of surface E- SELECTIN was also
observed in a subset of stimulated hESC-ECs. In summary,
hESC-ECs expressed high levels of ICAM-1 and low levels of
E-SELECTIN in response to TNFα stimulation, whilst HUVECs
also expressed VCAM-1, perhaps indicative of the latter's
greater maturity (Fig. 4, Supplementary Table 4).
Gelatin zymography was performed to evaluate the
ability of hESC-ECs to secrete matrix metalloproteinases
which, in vivo, allow EC migration when forming new
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111Derivation of endothelial cells from human embryonic stem cells in fully defined mediumbranches. These experiments indicated that both HUVECs
and d12 hESC-ECs secreted high amounts of MMP-2 and low
amounts of MMP-9 (Fig. 4D).
Transcriptional profiling identifies similarities
between hESC-ECs and postnatal endothelial cells
We compared the gene expression profiles of d6 CD34+KDR+
cells, d12–14 hESC-ECs and HUVECs cultured in our labora-
tory. We broadened the analysis by including comparisons
with a published array set generated from peripheral blood
and umbilical cord blood derived outgrowth endothelial cells
(OECs) and early endothelial progenitor cells (eEPCs), human
dermal microvascular endothelial cells (HDMECs) and pe-
ripheral blood monocytes (Medina et al., 2010) (Fig. 5,
Supplementary Fig. 2 and Supplementary Tables 5 and 6).
Differentially expressed genes were identified using signif-
icance analysis of microarrays (SAM), by comparing each of
these populations to undifferentiated hESCs. To identify
genes that were uniquely expressed in each sample or that
were expressed in common, probe sets representing
up-regulated genes from the two hESC-derived populations,
HUVECs and OECs were compared using overlap analysis (Fig.
5A and B). Functional annotation clustering of the core group
of genes (209 probe sets) up-regulated in all four populations
indicated a shared enrichment in genes associated with
blood vessel/vasculature development, and angiogenesis
(Supplementary Tables 5 and 6) including CDH5
(VE-CADHERIN), ENG (CD105/ENDOGLlIN) and NOS3 (eNOS),
as well as genes associated with cell migration and adhesion
including CD34, CD93, CD99, PECAM1 (CD31), ESAM, VMF
and ICAM2. In addition, all 4 populations expressed key
hemato-endothelial transcription factors such as TAL1,
GATA2, ELK3, SOX18, FLI1, HCLS1, HHEX and the homeobox
genes HOXB2, HOXB3, HOXB4, HOXB5 and HOXB7.
Analysis of transcripts expressed in d6 CD34+KDR+ cells
indicated that, in addition to the core group of genes, these
cells were enriched for transcripts encoding collagens and
integrins (COL1A2, COL3A1, COL4A5, COL4A6, COL5A1,
COL6A2, COL9A2, ITGA2B, ITAG5, ITGA8, ITGA9, ITGB2 and
ITGB3) and other cell adhesion molecules (ICAM2 and ICAM4,
PCDH10 and PCDH17). Day 6 CD34+KDR+ cells also expressed
many genes associated with hematopoiesis (ALAS2, HBD,
HBE1, HBG1, HBG2, HBZ, GATA1, GATA3, GATA4, GATA5,
GYPA, GYPB, GYPC, GYPE, IKZF1 (IKAROS), KEL, KLF1,MEIS1,
MEIS2, MYB), consistent with our hypothesis that this
population contained a mixture of blood and endothelial
progenitors.
Analysis of d12–14 hESC-ECs indicated that they were
enriched for mRNAs representing genes associated with
angiogenesis, vasculature development and blood vessel
morphogenesis (such as SOX17, SOX18, ANGPT2, EDN1,
NOTCH4, ROBO4, VEGFC and ENG) but showed a reductionFigure 4 hESC-ECs respond to the inflammatory mediator TNFα. H
cells were treated overnight with 10 ng/ml TNFα. A. Control and TN
expression of the indicated genes. B. Secreted ICAM-1, VCAM-1
represents the mean±s.e.m. of 3 independent experiments. *, p=
treated day 12 hESC-ECs and HUVECs to visualise the cell surface lev
constitutively expressed in both cell lineages with TNFα treatment
types. D. Gelatin zymography demonstrated that hESC-ECs and HUVin the expression of genes associated with haematopoiesis
compared to d6 CD34+KDR+ cells (Fig. 5C and Supplementary
Fig. 2 and Supplementary Tables 5 and 6). Furthermore,
hESC-ECs expressed genes associated with the maintenance
of vascular tone, such as eNOS, NOSTRIN, NOSIP, CAVEOLIN-1
and ENDOTHELIN −1. Overlap analysis indicated that many
genes up-regulated in d12–14 hESC-ECs were shared with
HUVECs (596/898 probes), and OECs (295/468 probes),
highlighting the similarity between hESC-ECs and these
developmentally more mature endothelial populations
(Fig. 5B). Notably, compared to HUVECs, hESC-ECs expressed
higher levels of NOSTRIN, and lower levels of genes involved
in fibrinolysis, such as SERPINB2, SERPINE1 and PLAT,
suggesting a level of functional immaturity in the hESC-
derived endothelium (Fig. 5C and D).
Comparisons between the transcriptional profiles of
hESC-ECs and the endothelial populations profiled by Medina
and colleagues highlighted the similarity between hESC-ECs
and bona fide endothelium, exemplified by HUVECs, OECs
and HDMECs, and the differences between these populations
and the monocyte related eEPC cells (Fig. 5D and Supple-
mentary Fig. 2). Pairwise comparisons demonstrated high
correlation coefficients between the gene expression data
representing hESC-ECs and the other endothelial populations
(r2=0.81–0.87) whilst lower correlation coefficients were
observed between that derived from hESC-ECs and the
monocyte-like eEPCs (r2=0.66–0.72) (Supplementary Fig.
2). Corroborating these data, we observed that the eEPCs
and peripheral blood monocytes did not express key
endothelial genes (Fig. 5D) and the transcriptional profiles
of these populations clustered away from hESC-ECs and
other endothelial cell types (Supplementary Fig. 2). Taken
together, our analyses indicated a high degree of transcrip-
tional similarity between hESC-ECs and several postnatal
endothelial cell populations.Subcellular localisation of eNOS in hESC-ECs is
regulated by serum-associated lipids
Given that hESC-ECs expressed key molecules associated
with NO regulation and production, we examined the
functionality of the eNOS regulatory network. We assessed
the cellular response of hESC-ECs to acetylcholine, known to
raise the level of cytosolic Ca2+, a precondition for eNOS
activation. Treatment of d12 hESC-ECs with acetylcholine
elicited in a rise in cytosolic Ca2+ levels (Fig. 6A). Immuno-
fluorescence analysis demonstrated that eNOS remained
concentrated in the perinuclear compartment, suggesting
accumulation in the golgi (Fig. 6B(i)). In contrast, in HUVECs
cultured in endothelial growth medium (EGM2), eNOS was
present in a punctate pattern, consistent with localisation in
the caveolae (Fig. 6B(v) and Supplementary Fig. 3), where itUVECs and day 12 hESC-ECs expanded from d6 sorted CD34+KDR+
Fα-treated hESC-ECs and HUVECS were analysed by RT-PCR for
and E-SELECTIN by hESC-ECs were quantified by ELISA. Data
0.02. C. Flow cytometry was performed on control and TNFα
els of ICAM-1, VCAM-1 and E-SELECTIN. VCAM-1 and ICAM-1 were
increasing cell surface expression of each marker in both cell
ECs secreted active MMP-2 and MMP-9.
112 M. Costa et al.is believed to associated with caveolin-1 (Govers et al.,
2002) (Supplementary Fig. 4A(v)).
The variation in subcellular localisation of eNOS between
hESC-ECs and HUVECs might reflect maturational differences
between the cell types or result from differences in the cultured1
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113Derivation of endothelial cells from human embryonic stem cells in fully defined mediumfailed to proliferate, supporting the notion that this medium
supported differentiation/maturation at the expense of prolif-
eration. Because EGM2-MV contains FGF2, EGF, and IGF in
addition to VEGF, we tested whether supplementation of AEL/
VEGF with these factors altered eNOS localisation within
hESC-ECs. However, as none of these factors affected eNOS
localisation (data not shown), we hypothesised that serum or
factors associated with the bovine serum albumin (BSA) present
in EGM2-MV medium might be regulating eNOS subcellular
localisation.
The APEL and AEL medium bases used for our experiments
contain only two lipid components – linolenic and linoleic
acid. Given that a broader range of lipids is present in serum
or complexed with BSA, we screened several candidate
molecules for their ability to influence hESC-EC morphology
and eNOS subcellular localization. Whilst supplementation
of medium with sphingosine-1-phosphate (S1P), sphingosine
or ceramide had little effect, treatment of d9 hESC-ECs with
lysophosphatidic acid (LPA) or platelet activating factor
(PAF) for more than 3 days resulted in redistribution of eNOS
to structures resembling caveolae (Fig. 6B(ii) and (iii),
Supplementary Fig. 4A(ii) and (iii)). Conversely, the intra-
cellular distribution of the abundant protein, NOSTRIN,
remained largely unchanged regardless of culture conditions
in both hESC-ECs and HUVECs (Supplementary Fig.
4B(i)–(vi).
To demonstrate that the effects of LPA and PAF on the
subcellular localisation of eNOS were not restricted to ECs
derived from HES3 hESC line, we generated ECs from H9 and
MEL1 hESC lines and the iPSC line Df 19-9-7T. Analysis of
these ECs demonstrated that eNOS was enriched in the
nuclear and the perinuclear regions and that LPA and PAF
treatment mediated a redistribution similar to that observed
for HES3 derived ECs (Supplementary Fig. 3). These data
illustrate that hESC-ECs derived and maintained in AEL/
VEGF media provide a platform suited to assess the effects
of factors that modulate EC phenotype and maturation.Discussion
We have developed a serum-free method for the efficient
generation of near pure populations of human ECs from
hESCs and demonstrated the flexibility and utility of this
system in identifying molecules that modulate endothelial
phenotype. CD34+KDR+ hematovascular mesodermal popu-
lation could be isolated by flow cytometry after 6 days ofFigure 5 Transcriptional profiling demonstrates similarity betw
harvested from undifferentiated hESCs, day 6 CD34+KDR+ isolated ce
analysed. Previously published data sets (http://www.ncbi.nlm.nih.
encompassing outgrowth endothelial cells (OECs), early endoth
endothelial cells (HDMECs) and monocytes were included in the an
that detected differential expression (Δ) between undifferentiated d
HUVECs and OECs, with the number of up-regulated (E) and down-
population are listed in Supplementary Table 5 and gene ontology
diagram demonstrating the overlap between the up-regulated probe
up-regulated in hESC-ECs, HUVECs and OECs are listed in Supplement
Table 6. C. Pairwise comparisons between the indicated populations
complete data set is shown in Supplementary Fig. 2. D. Heat map s
transcriptional profiles. The similarity between hESC-ECs and HUVECdifferentiation. The CD34+KDRhi (EC) population could be
further enriched and expanded by growth in defined
serum-free medium supplemented with VEGF. These condi-
tions did not support the growth or blood forming potential
of the CD34+KDRlo fraction. The observation that KDR
expression levels can be used to selectively enrich for
endothelial versus hematopoietic progenitors mirrors prior
studies indicating these two populations can be distin-
guished on the basis of CD34 expression levels. However, at
d6 of differentiation, differences between the level of CD34
expression in these two pools is less clear (see Fig. 2).
Therefore, we hypothesise that differential KDR expression
levels precede the up-regulation of CD34 associated with
more differentiated endothelial progenitors.
The observation that CD34+KDRlo cells do not proliferate
in AEL/VEGF medium means that, hypothetically, cells may
only need to be sorted on the basis of CD34 expression in
order to generate a pure population of EPCs. If this
hypothesis proved correct, other less stringent enrichment
techniques (such as MACS, Miltenyi Biotech) could be used to
purify CD34+ EPCs and subsequently generate large quanti-
ties of endothelial cells.
Human ESC-ECs expressed endothelial cell adhesion
molecules such as ICAM1, vWF and eNOS, formed vessel-
like structures in matrigel and took up Ac-LDL. These
findings are consistent with characteristics of hESC-derived
ECs described by others (Bai et al., 2010; Boyd et al., 2007;
James et al., 2010; Li et al., 2009; Nakahara et al., 2009;
Prado-Lopez et al., 2010; Sun et al., 2012; Tatsumi et al.,
2011; Wang et al., 2007). In addition, our analysis of CD31
localisation in day 6 EBs indicated that this surface
molecule formed an intricate lattice suggestive of its
localisation to cell-cell junctions (Supplementary Fig. 5).
Nevertheless, further confirmation of the EC character of
the cells generated using this protocol might include a more
detailed analysis of proteins associated with cell-cell
junctions as well as in vivo functional studies; studies
which are beyond the scope of this report.
Transcriptional profiling of endothelial populations
derived from cord blood, peripheral blood and adult tissues
has assisted in the elucidation of the lineage relationships
of several different endothelial progenitor cell types
(reviewed in Gremmels et al., 2011). Circulating endothe-
lial progenitors classified as early endothelial progenitor
cells (eEPCs) or circulating angiogenic cells (CACs) grow on
fibronectin-coated dishes. These cells secrete growth
factors that influence angiogenesis but it appears that theeen hESC-ECs and postnatal endothelial cells. Total RNA was
lls, day 12–14 hESC-ECs and HUVECs and transcriptional profiles
gov/geo with accession number GSE20283) (Medina et al., 2010)
elial progenitor cells (eEPCs), human dermal microvascular
alysis. A. Schematic demonstrating the total number of probes
0 hESCs and day 6 CD34+KDR+ isolated cells, day 12–14 hESC-ECs,
regulated probes (z) indicated. The genes up-regulated in each
groupings shown in Supplementary Table 6. B. Four-way Venn
s. The probe sets up-regulated in all four populations and those
ary Table 5 and gene ontology groupings shown in Supplementary
showing the number of probe sets differing by N5-fold. A more
howing the expression of key genes in the entire data set of 22
s, OECs and HDMECs is evident. See text for further details.
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Figure 6 eNOS localisation in day 12 hESC-ECs and HUVECs. A. Acetylcholine treatment of day 12 hESC-ECs resulted in a Ca2+ influx.
Upper panels show fluorescence images of Fluo-4-AM loaded hESC-ECs before and after treatment with 10 μmol/l acetylcholine.
Lower panel shows relative changes in Fluo-4-AM derived fluorescence in response to period acetylcholine treatment as indicated.
Traces representing data from multiple cells are shown. B. Day 9 CD34+KDR+ cells were seeded onto glass coverslips and cultured with
(i) AEL/VEGF, (ii) AEL/VEGF/LPA, (iii) AEL/VEGF/PAF, or (iv) EGM-2 MV for a further 3–4 days. The cells were fixed, stained with an
anti-eNOS antibody and imaged by confocal microscopy (original magnification ×120). HUVECs (v) and undifferentiated hESCs (vi)
were included as positive and negative controls. In the presence of AEL/VEGF, eNOS is predominantly located in the nucleus and the
perinuclear golgi compartments (arrows). Treatment of hESC-ECs with LPA, PAF, or EGM-2 MV medium leads to eNOS distribution
throughout the cell, similarity to the pattern observed in HUVECs. hESCs also express eNOS and located in the nucleus. C. hESC-ECs
cultured in AEL/VEGF were also stained with an antibody which recognises the 58K Golgi marker. Structures identified by this
antibody resemble those in which eNOS localised in cells grown under the same conditions (panel B(i)).
114 M. Costa et al.eEPC may share more in common with monocytes than with
endothelium (reviewed in Gremmels et al., 2011; Medina
et al., 2010). Conversely, outgrowth endothelial cells
(OECs), otherwise known as endothelial colony forming
cells (ECFCs), are preferentially cultured on a collagen
substrate and can directly incorporate into vasculature
(Mukai et al., 2008; Sieveking et al., 2008). In this study,
we have shown that the d12–14 hESC-ECs grown in AEL/
VEGF medium were most similar to OECs and the more
mature HUVECs and HDMECs, not hematopoietic or mono-
cyte progenitors, confirming their bona fides as true
endothelial cells. At the transcriptional level, hESC-ECsdiffered from postnatal endothelial populations in that the
former displayed persistent CD34 expression, detectable
levels of embryonic and fetal globin expression and low
levels of VCAM1, SELE, SERPINB1, SERPINE1 and PLAT
expression. We speculate that these differences might
reflect the relative immaturity of the hESC-ECs, perhaps
contributed to by the absence of key lipids in the culture
medium. The overall similarity between ECs isolated from
different sources or cultured under different conditions is
only now beginning to be explored at the transcriptional
level. In this context, transcriptional profiling of hESC-ECs
treated with circulating lipids such as LPA and PAF and a
115Derivation of endothelial cells from human embryonic stem cells in fully defined mediumcomparison with other published EC datasets would further
clarify the relationship between in vitro derived hESC-ECs
and EC populations from different in vivo sources.
Most published protocols for the endothelial differentia-
tion of hESCs employ stromal co-culture (Boyd et al., 2007;
Vodyanik et al., 2005) or utilise media with undefined or
animal derived components such as serum, albumin frac-
tionated from bovine serum, conditioned media or extracel-
lular matrices (Chen et al., 2007; Ferreira et al., 2007; Kane
et al., 2010; Lagarkova et al., 2008; Levenberg et al., 2010;
Li et al., 2008; Prado-Lopez et al., 2010; Sun et al., 2012;
Wang et al., 2007). Albumin, a common constituent in many
formulations, is an avid transporter of lipids and hormones,
whose composition may vary based on the source. In
contrast, our studies used a fully defined base culture
medium, denoted APEL (Ng et al., 2008), that contained only
recombinant human proteins (albumin, transferrin and
insulin). In addition, EB, rather than monolayer differenti-
ation, was highly efficient and generally yielded ~40%
CD34+KDR+ progenitor cells after 6 days of differentiation.
In HUVECs that are cultured in serum-containing medium,
eNOS is thought to be associated with caveolae, invaginated
plasma membrane micro-domains rich in cholesterol and
sphingolipids (Govers and Rabelink, 2001), where it is found in
association with caveolin-1 (Govers et al., 2002). The intracel-
lular localisation of eNOS in HUVECs is reportedly also
influenced by cell density. In sub-confluent cultures, eNOS is
predominantly confined to the golgi whereas in dense cultures,
eNOS is found in the caveolae (Govers et al., 2002; Liu et al.,
1997; Sessa et al., 1995). However, eNOS in hESC-ECs cultured
in APEL medium was similarly concentrated in a perinuclear
compartment, consistent with golgi localisation.
The highly defined nature of our culture system enabled us
to identify LPA and PAF as factors that induced redistribution
of eNOS such that it subcellular localisation resembled that
seen in HUVECs. LPA is associated with cellular proliferation
(van Corven et al., 1989), wound healing, adhesion and cell
migration (Moolenaar, 1995) whilst PAF is a mediator of
leukocyte adhesion to the endothelium and also regulates
vessel tone. In the systemic vasculature, PAF elevates NO
production and vascular permeability, whilst mediating
bronchoconstriction in lung endothelial cells (Kuebler et al.,
2010). In the circulation, both LPA (Eichholtz et al., 1993) and
PAF (Clay et al., 1990) are present in albumin-containing
complexes. Our data are consistent with the hypothesis that
exogenous factors known to be present in serum can influence
the phenotypic characteristics of ECs.Conclusion
We describe a method for the generation of a uniform
population of ECs from hESCs differentiated in serum-free
completely defined conditions. We have demonstrated the
utility of this defined differentiation protocol for probing EC
biology by identifying two lipids, LPA and PAF, that affected
the subcellular localisation of eNOS in hESC-ECs. These
findings could not have been discerned if the cells had been
exposed to serum or conventional EC culture media or if we
had utilised endothelial cell types dependent on serum in
their culture media, such as HUVECs. In this context, the
system we describe represents a unique platform for theongoing analysis of factors influencing both human EC
differentiation and maturation.
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